Health Invest Partners Ab has filed its 13F form on July 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $221 Million distributed in 37 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $30.2M, Abb Vie Inc. with a value of $16.1M, Boston Scientific Corp with a value of $13.6M, Neurocrine Biosciences Inc with a value of $11.1M, and Merck & Co., Inc. with a value of $11M.
Examining the 13F form we can see an increase of $5.85M in the current position value, from $215M to 221M.
Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.